Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
NVOS holding history
Novo Integrated Sciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVOS overviewAll 13F holders of NVOSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −5−100.0% | Sold out | Holders |
| Q3 2024 | 5 | $1 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 5 | $4 | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q3 2023 | 50 | $15 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 50 | $7 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 50 | $6 | <0.1% | +32+177.8% | Added | Holders |
| Q4 2022 | 18 | $4 | <0.1% | +18 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −114,672−100.0% | Sold out | Holders |
| Q2 2021 | 114,672 | $288.0K | <0.1% | +114,672 | New | Holders |